Akesobio set to launch $300m Hong Kong IPO
Chinese biopharmaceuticals firm Akesobio is preparing to launch bookbuilding for its IPO next week, according to a source close to the deal.
JP Morgan and Morgan Stanley are running the show as the sponsors. The duo kicked off pre-marketing for the deal this week and are set to open books in the week of April 13.
The listing is expected to raise about $300m, said the source.Akesobio is a clinical-state biopharmaceuticals ...
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: email@example.com